Metraipolis › archive › dc_8e4baeaaeda4

Development and Validation of a Rapid Titer Assay for the Oncolytic Virus oHSV2 Expressing a PD-L1/CD3 Bispecific Antibody — Europe PMC PMID:42515546

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42515546
DOI
10.3390/v18070694
License (as archived)
solo-consultazione
Archived
2026-10-19T04:20:07.096Z
SHA-256 of the archived text
a697a4724b29c7733d0cffb2508151e81001fe3d51e9acb124e640329f3804f9
Stable URL of this page
https://metraipolis.com/documento/dc_8e4baeaaeda4

How to cite

Development and Validation of a Rapid Titer Assay for the Oncolytic Virus oHSV2 Expressing a PD-L1/CD3 Bispecific Antibody — Europe PMC PMID:42515546 — Europe PMC (en), https://europepmc.org/article/MED/42515546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8e4baeaaeda4 (Metraipolis archive dc_8e4baeaaeda4, sha256 a697a4724b29c7733d0cffb2508151e81001fe3d51e9acb124e640329f3804f9)
BibTeX
@misc{dc8e4baeaaeda4,
  title = {Development and Validation of a Rapid Titer Assay for the Oncolytic Virus oHSV2 Expressing a PD-L1/CD3 Bispecific Antibody — Europe PMC PMID:42515546},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42515546},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8e4baeaaeda4; sha256 a697a4724b29c7733d0cffb2508151e81001fe3d51e9acb124e640329f3804f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42515546. Agents can read the archived copy with the MCP tool read_document.